Objective-Nitro-fatty acids (NO 2 -FAs) are emerging as a new class of cell signaling mediators. Because NO 2 -FAs are found in the vascular compartment and their impact on vascularization remains unknown, we aimed to investigate the role of NO 2 -FAs in angiogenesis. Methods and Results-The effects of nitrolinoleic acid and nitrooleic acid were evaluated on migration of endothelial cell (EC) in vitro, EC sprouting ex vivo, and angiogenesis in the chorioallantoic membrane assay in vivo. At 10 mol/L, both NO 2 -FAs induced EC migration and the formation of sprouts and promoted angiogenesis in vivo in an NO-dependent manner. In addition, NO 2 -FAs increased intracellular NO concentration, upregulated protein expression of the hypoxia inducible factor-1␣ (HIF-1␣) transcription factor by an NO-mediated mechanism, and induced expression of HIF-1␣ target genes, such as vascular endothelial growth factor, glucose transporter-1, and adrenomedullin. Compared with typical NO donors such as spermine-NONOate and deta-NONOate, NO 2 -FAs were slightly less potent inducers of EC migration and HIF-1␣ expression. Short hairpin RNA-mediated knockdown of HIF-1␣ attenuated the induction of vascular endothelial growth factor mRNA expression and EC migration stimulated by NO 2 -FAs. Conclusion-Our data disclose a novel physiological role for NO 2 -FAs, indicating that these compounds induce angiogenesis in an NO-dependent mechanism via activation of HIF-1␣. Key Words: angiogenesis Ⅲ nitric oxide Ⅲ hypoxia inducible factor-1 Ⅲ nitro-fatty acids N itro-fatty acids (NO 2 -FAs) are nitroalkene products of polyunsaturated fatty acids, nitrated by nitric oxide (NO)-derived species. 1 NO 2 -FAs, including nitrolinoleic acid (LNO 2 ) and nitrooleic acid (OA-NO 2 ), have pluripotent cell signaling capabilities. For example, they exhibit antiinflammatory properties by inhibiting platelet aggregation and neutrophil activation 2 and upregulating heme oxygenase-1 expression. 3 Recently, the ability to nitrosate CD40 4 and potential cardioprotective effects have also been ascribed to these compounds. 5 Interestingly, OA-NO 2 was found in reperfused ischemic heart tissue, indicating that its formation might occur during the reperfusion process. Moreover, exogenous administration of OA-NO 2 also mitigates the damage induced by tissue reoxygenation. 5 NO 2 -FAs also activate the peroxisome proliferator-activated receptor-␥ 6 and might mediate reversible posttranslational protein modifications through nitroalkylation reactions both with low-molecularweight thiols and with cysteine and histidine residues of proteins. 2 Furthermore, NO 2 -FAs not only serve as reservoirs for NO but also may act as endogenous NO donors, 4, 7 inducing vessel relaxation 8,9 and upregulating endothelial NO synthase expression and activity, ultimately increasing NO levels. 10 NO is a well-established modulator of angiogenesis, 11 which is a crucial process during embryonic development and in several pathological conditions, including vascular diseases. 12 Angiogenesis is tightly regulated by a balance between pro-and antiangiogenic mediators that modulate migration, proliferation, proteolytic activity, and differentiation of endothelial cells (ECs). 13 Current data indicate that the NO-mediated angiogenic response might be promoted by the inhibition of apoptosis, 14 enhanced EC migration, 15 and induction and release of the vascular endothelial growth factor (VEGF). 16 In addition, there are several reports demonstrating that exposure of cells to NO donors increases the activity of hypoxia-inducible factor-1 (HIF-1). [17] [18] [19] [20] HIF-1 is a basic helix-loop-helix transcription factor composed of a constitutively expressed ␤ subunit and an oxygensensitive ␣ subunit, 21 and it is appreciated as the most important transcription factor in the angiogenic process.
N itro-fatty acids (NO 2 -FAs) are nitroalkene products of polyunsaturated fatty acids, nitrated by nitric oxide (NO)-derived species. 1 NO 2 -FAs, including nitrolinoleic acid (LNO 2 ) and nitrooleic acid (OA-NO 2 ), have pluripotent cell signaling capabilities. For example, they exhibit antiinflammatory properties by inhibiting platelet aggregation and neutrophil activation 2 and upregulating heme oxygenase-1 expression. 3 Recently, the ability to nitrosate CD40 4 and potential cardioprotective effects have also been ascribed to these compounds. 5 Interestingly, OA-NO 2 was found in reperfused ischemic heart tissue, indicating that its formation might occur during the reperfusion process. Moreover, exogenous administration of OA-NO 2 also mitigates the damage induced by tissue reoxygenation. 5 NO 2 -FAs also activate the peroxisome proliferator-activated receptor-␥ 6 and might mediate reversible posttranslational protein modifications through nitroalkylation reactions both with low-molecularweight thiols and with cysteine and histidine residues of proteins. 2 Furthermore, NO 2 -FAs not only serve as reservoirs for NO but also may act as endogenous NO donors, 4, 7 inducing vessel relaxation 8, 9 and upregulating endothelial NO synthase expression and activity, ultimately increasing NO levels. 10 NO is a well-established modulator of angiogenesis, 11 which is a crucial process during embryonic development and in several pathological conditions, including vascular diseases. 12 Angiogenesis is tightly regulated by a balance between pro-and antiangiogenic mediators that modulate migration, proliferation, proteolytic activity, and differentiation of endothelial cells (ECs). 13 Current data indicate that the NO-mediated angiogenic response might be promoted by the inhibition of apoptosis, 14 enhanced EC migration, 15 and induction and release of the vascular endothelial growth factor (VEGF). 16 In addition, there are several reports demonstrating that exposure of cells to NO donors increases the activity of hypoxia-inducible factor-1 (HIF-1). [17] [18] [19] [20] HIF-1 is a basic helix-loop-helix transcription factor composed of a constitutively expressed ␤ subunit and an oxygensensitive ␣ subunit, 21 and it is appreciated as the most important transcription factor in the angiogenic process.
Under normoxic conditions, HIF-1␣ is degraded by a mechanism involving hydroxylation by specific prolyl hydroxylases, ubiquitylation, and proteasomal degradation through a von Hippel-Lindau protein-dependent pathway. At low oxygen levels, prolyl hydroxylase activity decreases, thereby allowing HIF-1␣ stabilization, nuclear translocation, dimerization with HIF-1␤, and binding to hypoxia-response elements in the promoters of target genes. 22 Besides hypoxia, there is an increasing body of evidence demonstrating that HIF-1␣ might be upregulated under normoxia in response to a number of stimuli, including growth factors, lipopolysaccharides, cytokines, the supernatant of apoptotic cells, reactive oxygen species, and NO. 23 In this study, we analyzed the effects of 2 NO 2 -FAs, LNO 2 and OA-NO 2 , on angiogenesis. Our data demonstrate that both LNO 2 and OA-NO 2 induce EC migration and ex vivo sprouting, as well as angiogenesis in vivo. We also present evidence that the proangiogenic effects of NO 2 -FAs are mediated via NO-and HIF-1␣-dependent mechanisms. Taken together, these findings reveal a novel biological effect of NO 2 -FAs.
Materials and Methods

Reagents
Tissue culture media, serum, and supplements were purchased from Gibco. Linoleic acid (LA), oleic acid (OA), antiactin antibody, anti-␤-tubulin antibody, bovine hemoglobin (Hb), 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (cPTIO) and L-NG-nitroarginine methyl ester (L-NAME) were purchased from Sigma-Aldrich. 12-LNO 2 was synthesized and purified as described previously. 8 Specifically, the purity of the 12-LNO 2 used in this study was Ն98%, which was determined by mass spectrometry. 9-OA-NO 2 , spermine-NONOate (sper/NO), diethylenetriamine-NONOate (deta/NO), and 1H- [1, 2, 4] oxadiazolo [4,3-a] quinoxalin-1-one were purchased from Cayman Chemicals. The anti-HIF-1␣ antibody was purchased from BD Biosciences, and 4-amino-5-methylamino-2Ј,7Ј-difluorofluorescein diacetate (DAF-FM diacetate) was obtained from Molecular Probes Inc.
Cell Culture
Human umbilical vein ECs (HUVECs) were maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS), 100 IU/mL penicillin, and 100 g/mL streptomycin. The human endothelial-like immortalized cell line EA.hy926, derived from the fusion of HUVECs with the lung carcinoma cell line A549 (kindly provided by Dr C.J. Edgell, University of North Carolina), was cultured in high-glucose Dulbecco's modified Eagle's medium supplemented with 10% FBS, penicillin/streptomycin mixture, 1% glutamine, 5 mmol/L hypoxanthine, 0.02 mmol/L aminopterin, and 0.8 mmol/L thymidine. Cells were incubated at 37°C with 5% CO 2 and stimulated with NO 2 -FAs in medium containing 1% FBS. Control cells were treated with the lipid vehicle, ethanol, at concentrations used for NO 2 -FAs (Ͻ0.1% vol/vol).
Lentiviral Knockdown
To create EA.hy926 cell lines with a stable knockdown of HIF-1␣, lentiviruses coding for HIF-1␣ short hairpin RNA (shRNA) or nontargeting control shRNA (Mission shRNA, Sigma-Aldrich) were packaged and produced in 293T cells according to manufacturer instructions. EA.hy926 cells were infected, and lentivirally transduced EA.hy926 clones were selected with the addition of 5 g/mL puromycin. The efficiency of HIF-1␣ knockdown was confirmed by quantitative reverse transcription-polymerase chain reaction (realtime PCR) and Western blot analysis.
Migration Assay
EC migration was analyzed using an in vitro scratch assay as previously described. 24 Briefly, confluent EC monolayers were scratched with a sterile pipette tip, rinsed, and incubated for 24 hours with RPMI-1% FBS (HUVEC) or DMEM-1% FBS (EA.hy926) containing 10 mol/L LA, LNO 2 , OA, OA-NO 2 , sper/NO, or deta/NO. Immediately after wounding and at the end of the experiment, the wound areas were photographed. The AxioVision 4.0 software (Carl Zeiss) was used to determine the extent of migration by counting the number of cells that moved into the scratched area in 3 distinct microscopic fields representative of each culture plate. Each experiment was performed in triplicate and repeated 3 times.
Aortic Ring Assay
The rat aortic ring assay was performed as described previously. 25 In brief, 1-mm aortic rings obtained from 2-month-old male Wistar rats were embedded in 3-dimensional rat collagen I gels (2 mg/mL). After collagen polymerization, each well was overlaid with 1.2 mL MCDB131 medium containing vehicle, LA, LNO 2 , OA, or OA-NO 2 , respectively, and the aortic rings were incubated for up to 8 days at 37°C with 5% CO 2 . Aortic explants were photographed at day 8, and the angiogenic response was quantified by measuring the length of capillary-like sprouts originating from the cultured aortic ring at a ϫ10 magnification using a computer-assisted image analysis system. Each experiment was performed with at least 7 samples each time and repeated 3 times.
In Vivo Angiogenesis Assay
The chicken chorioallantoic membrane (CAM) assay was performed as previously described 26 with some modifications. Fertilized chicken eggs were incubated at 37°C in 60% relative humidity. At day 3, a square window was opened in the egg shell under laminar flow, egg albumin was removed, and the window was sealed with tape. After 5 days, hydrocortisone-pretreated 5-mm filter disks were placed onto the CAMs, and vehicle, LA, LNO 2 , OA, or OA-NO 2 was added to the disk at 0, 24, and 48 hours. After 72 hours, CAMs were removed and fixed, and the discs were analyzed by stereomicroscopy. Angiogenesis was quantified by analyzing the number of new branching blood vessels within the area of each disk. The number of new vessels was normalized to the length of the preexisting one. A minimum of 18 filter disks per group were studied.
Western Blotting
Western blot analysis was performed as previously described. 17 Briefly, cells treated as indicated were washed with ice-cold PBS, scraped off, lysed in 50 L of lysis buffer, and sonicated followed by centrifugation (15 000g, 15 minutes). The protein amount was quantified using the bicinchoninic acid assay (Pierce), and 100 g of total protein was loaded on 10% SDS-polyacrylamide gels and blotted onto nitrocellulose membranes. The membranes were blocked with 5% (wt/vol) defatted milk powder in Tris-buffered saline (TBS) containing 0.1% Tween 20 for 2 hours followed by incubation with HIF-1␣-antibody (1:1000 in 5% milk/TBS/Tween) overnight at 4°C. Afterward, the membranes were washed once for 5 minutes with TBS/Tween and twice for 5 minutes with TBS. Blots were then incubated with a horseradish peroxidase-labeled goat anti-mouse secondary antibody (1:2000 in 5% milk/TBS/Tween) for 1 hour followed by enhanced chemiluminescence detection (GE Healthcare).
Quantitative Real-Time PCR Analysis
Total RNA was isolated with Trizol (Invitrogen), and 2 g of RNA was reverse-transcribed into cDNA by SuperScript III reverse transcriptase (Invitrogen). Quantitative real-time PCR was performed in an ABI Prism 7700 sequence detector (Applied Biosystems) using SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA) and specific primer pairs for HIF-1␣ (forward, 5Ј-GCTGGCCCCAGCCG CTGGAG-3Ј; reverse, 5Ј-GAGTGCAGGGTCAGCACTAC-3Ј), VEGF (forward, 5Ј-ATCTTCAAGCCATCCTGTGTGC-3Ј; reverse, 5Ј-CAAGGCCCACAGGGATTTTC-3Ј), glucose transporter-1 (GLUT-1; forward, 5Ј-TCACTGTGCTCCTGGTTCTG-3Ј; reverse, 5Ј-CCTGTGCTCCTGAGAGATCC-3Ј), adrenomedullin (ADM; forward, 5Ј-GGATGCCGCCCGCATCCGAG-3Ј; reverse, 5Ј-GACACCAGAG TCCGACCCGG-3Ј), and 18S rRNA (forward, 5Ј-GTAACCCGTTG AACCCCATT-3Ј; reverse, 5Ј-CCATCCAATCGGTAGTAGCG-3Ј). The cycling program was 95°C for 15 minutes, followed by 40 cycles of 95°C for 15 seconds and 60°C for 60 seconds. Each sample was run in triplicate. Expression of each target gene was normalized to 18S rRNA relative expression as an internal efficiency control. Values are expressed as fold increases relative to the untreated control.
NO Measurement
The effect of LNO 2 and OA-NO 2 on NO production was assayed using DAF-FM diacetate, a cell-permeable NO-sensitive fluorescent dye. Before experimental interventions, HUVECs cultured in a temperature-controlled culture dish were incubated in RPMI medium containing 5 mol/L DAF-FM diacetate for 45 minutes at 37°C in the dark. After loading, cells were rinsed 3 times with PBS to remove excess probe and then incubated for an additional 30 minutes with fresh medium to allow complete deesterification of the intracellular diacetates. Cells were maintained at 37°C with a heating ring and randomly selected, and images were obtained using a Zeiss confocal laser scanning microscope. NO fluorescence was measured using excitation and emission wavelengths of 488 and 515 nm, respectively. LNO 2 , OANO 2 , sper/NO or deta/NO were added to the cells, and DAF-FM diacetate fluorescence intensity was determined in real time, with 1-second scans obtained every 3 minutes. Intensity of fluorescence was quantified using the LSM 510 (version 3.0 SP3) software for the Carl Zeiss laser scanning microscope.
Data Analysis
All results are expressed as the meanϮSD from triplicate measurements performed in at least 2 or 3 independent experiments. Statistical analysis was performed by 1-way ANOVA followed by the Tukey test. Probability values were considered significant at PϽ0.05.
Results
LNO 2 and OA-NO 2 Induce EC Migration by NO-Dependent Mechanisms
To assess potential EC migration-promoting effects of NO 2 -FAs, scratch migration assays were performed. The concentration of the NO 2 -FAs used in our in vitro experiments was selected on the basis of previous reports describing biological actions of NO 2 -FAs. 3, 4 As illustrated in Figure 1A and 1B, NO 2 -FAs significantly increased HUVEC migration, which was approximately 2-to 3-fold enhanced compared with controls. Importantly, neither the vehicle nor unmodified fatty acids induced HUVEC migration.
To elucidate the potential contribution of NO to NO 2 -FAsmediated cell migration, we pretreated wounded HUVECs for 1 hour or 15 minutes with the NO scavengers cPTIO (100 mol/L) or Hb (10 mol/L), respectively, followed by the treatment with 10 mol/L LNO 2 or OA-NO 2 for 24 hours. Two different NO-donors, sper/NO and deta/NO (10 mol/L each), were used as positive controls for NO-stimulated cell migration. As expected, treatment of cells with both NO donors enhanced cell migration ( Figure 1C and 1D) . Interestingly, pretreatment with either cPTIO or Hb abolished the stimulatory effects of NO 2 -FAs ( Figure 1E) .
We also investigated the role of endogenous NO and cGMPdependent pathways in the NO 2 -FAs-induced cell migration. The ability of both NO 2 -FAs to enhance cell migration decreased by preexposing cells for 30 minutes with the selective soluble guanylyl cyclase inhibitor (10 mol/L). However, the presence of the nitric oxide synthase inhibitor L-NAME at 500 mol/L did not significantly change NO 2 -FA-induced EC migration ( Figure 1F ).
To confirm that NO 2 -FAs raise intracellular NO concentration, we used the NO-specific fluorescent molecule DAF. Confocal microscopic analyses showed that stimulation with both NO 2 -FAs increased intracellular DAF fluorescence, substantiating NO production. Maximum NO production induced by LNO 2 was approximately 2.5-fold and occurred at 40 minutes, whereas exposure to OA-NO 2 led a maximum response (3.1-fold) at 9 minutes. The addition of equivalent concentrations of either sper/NO or deta/NO produced comparable cytosolic fluorescence signals and, as expected, sper/NO led to a more transient burst of NO release, whereas deta/NO caused gradual increase of DAF fluorescence ( Figure 1G ).
In summary, these results support the idea that NO 2 -FAs are capable of releasing NO, thereby increasing intracellular NO levels that ultimately promote EC migration through an NO-dependent mechanism.
NO 2 -FAs Stimulate EC Sprouting Ex Vivo and Angiogenesis In Vivo
Next, we examined the effects of NO 2 -FAs on a model system of angiogenesis that closely recapitulate the process of sprouting angiogenesis observed in vivo. Using the ex vivo aortic ring assay, we observed that angiogenesis was stimulated by 10 mol/L OA-NO 2 or LNO 2 , whereas no sprouting was detected in untreated or vehicle-treated aortic segments (Figure 2A and 2B) . Pretreatment with cPTIO successfully abolished the proangiogenic response to NO 2 -FAs, whereas unmodified fatty acids did not affect sprouting of new vessels in the ex vivo system ( Figure 2C and 2B) .
We then determined the impact of NO 2 -FAs on angiogenesis by evaluating vessel formation in the CAM assay. As illustrated in Figure 3 , the application of either 10 mol/L LNO 2 or 10 mol/L OA-NO 2 to 8-day-old CAMs increased neovascularization in comparison to the control. Again, no angiogenic effect was evident in CAMs treated with either LA or OA (Figure 3 ).
HIF-1␣ Protein Is Increased by NO 2 -FAs
Because HIF-1 is induced by NO under normoxia and is considered one of the master transcription factors inducing 
OA-NO 2 and LNO 2 Induce Gene Expression Downstream of HIF-1
To confirm the functionality of HIF-1␣ induction by NO 2 -FAs, we evaluated the expression of different HIF-1 target genes. As depicted in Figure 5 , both NO 2 -FAs transiently stimulated the expression of GLUT-1, ADM and VEGF mRNAs. Treatment with 10 mol/L OA-NO 2 for 4 hours caused an approximately 5-fold induction of ADM and VEGF, as well as a 2.5-fold increase of GLUT-1 mRNA expression. In turn, the exposure to LNO 2 showed a similar induction at 6 hours, upregulating GLUT-1, ADM, and VEGF by 4.4-, 4.8-, and 6.3-fold, respectively. In addition, mRNA expression of GLUT-1, ADM, and VEGF in response to NO 2 -FAs was not restricted to HUVECs but could also be seen in EA.hy926 (Supplemental Figure II) . Furthermore, incubation with sper/NO or deta/NO for 4 hours likewise provoked a significant increase of HIF-1 target genes, as observed with NO 2 -FAs ( Figure 5B ). Because VEGF is a key angiogenic factor, we assessed the involvement of NO in NO 2 -FAs-induced VEGF expression in HUVECs by pretreating cells with 100 mol/L cPTIO for 1 hour. As can be seen in Figure 5C , the increase in VEGF expression by LNO 2 and OA-NO 2 at 6 and 4 hours, respectively, was completely inhibited in the presence of cPTIO.
Proangiogenic Effects of LNO 2 and OA-NO 2 Were Mediated by HIF-1␣
As an additional approach to demonstrate that proangiogenic effects of NO 2 -FAs are mediated by HIF-1, EA.hy926 cells with stable knockdown of HIF-1␣ were generated. The efficacy of HIF-1␣ lentiviral knockdown was confirmed by real-time PCR and Western analysis ( Figure 6A and 6B) . In particular, HIF-1␣ mRNA expression was decreased by 96%, and protein expression was basically undetectable. We next confirmed that the NO 2 -FAs-induced VEGF expression was completely eliminated in HIF-1␣ knockdown cells and, thus, was HIF-1 mediated ( Figure 6C ). To show the involvement of HIF-1␣ in the ability of NO 2 -FAs to stimulate EC migration, the wound scratch assay was repeated with HIF-1␣ knockdown cells. Notably, the knockdown of HIF-1␣ by lentiviral shRNA completely abrogated the effect of NO 2 -FAs on EC migration ( Figure 6D and 6E), whereas transduction of scrambled shRNA still allowed migration in response to NO 2 -FAs. Together, these data suggest that HIF-1␣ is essential for the proangiogenic response of ECs to LNO 2 and OA-NO 2.
Discussion
Here we present the first evidence that 2 NO 2 -FAs, LNO 2 and OA-NO 2 , promote angiogenesis. By using a combination of in vitro, ex vivo, and in vivo assays, our data support the notion that both LNO 2 and OA-NO 2 induce essential steps of the neovascularization process, such as EC migration and vessel sprouting and are capable of stimulating angiogenesis in vivo. Notably, the proangiogenic effects of NO 2 -FAs are likely to be mediated by NO-and HIF-1␣-dependent signaling mechanisms.
Previous reports demonstrate that inflammation and angiogenesis are tightly linked processes. 27 Because NO 2 -FAs are reported to be endogenous byproducts of nitrooxidative inflammatory reactions 1 and biologically active compounds, 2-6,9,10 these molecules might represent important mediators of neovessel formation during inflammation-associated angiogenesis. In this study, we provide compelling evidence showing proangiogenic effects of NO 2 -FAs. Unlike their nitrated derivatives, linoleic and oleic acids had no such effects. Importantly, the NO 2 -FAs-elicited proangiogenic response was completely abolished in the presence of NO scavengers such as cPTIO and Hb. These findings suggest that NO 2 -FAs-induced EC migration and sprouting are facilitated by NO. Because the NOS inhibitor L-NAME did not significantly affect the angiogenic response to NO 2 -FAs, NOS activation by NO 2 -FAs seems unlikely under our experimental conditions. NO is involved in several signaling pathways, and it is widely established that this molecule, either delivered from NO-donors or endogenously generated by NOS, influences EC migration, thus favoring angiogenesis. 11 Corroborating previous studies, 15, 28 we demonstrated that 2 different NO donors display qualitatively similar effects as NO 2 -FAs on EC migration. Furthermore, we detected an involvement of soluble guanylyl cyclase, an NO downstream target, because decreased cell migration was observed in the presence of 1H- [1, 2, 4] oxadiazolo [4,3-a] quinoxalin-1-one. This is in line with previously published data 29 -31 demonstrating that low to moderate concentrations of NO affect angiogenesis in EC by activating sGC. Moreover, we provide evidence that exposure of EC to NO 2 -FAs increased intracellular NO concentration. Taken together, these results support the concept of NO release from NO 2 -FAs, which in turn promotes angiogenesis in ECs. In fact, recent data 4, 7, 8, 32 pointed out that LNO 2 and OA-NO 2 act as direct reservoirs for NO 4, 8 and release NO via a Nef reaction. 7 Regardless of the mechanism involved in the increase in bioavailable NO in response to NO 2 -FAs, our data suggest that both stabilization and activation of HIF-1 are required to promote angiogenesis. Previous studies demonstrate that HIF-1 activation induces a variety of genes related to erythropoiesis, glucose metabolism, pH regulation, and, importantly, angiogenesis. 22 To date, VEGF is by far the bestcharacterized target in the HIF-induced angiogenesis process. 33 Our data indicate that both NO 2 -FAs not only increase the HIF-1␣ protein but also cause HIF-1 transcriptional activation. In turn, HIF-1 activates well-established target genes, such as GLUT-1, ADM, and VEGF. Experimental evidence obtained by scavenging NO further demonstrates that increased HIF-1␣ protein accumulation and VEGF mRNA expression are NO mediated. These observations are in agreement with our results using NO donors and other studies demonstrating HIF-1␣ activation and subsequent VEGF upregulation as a consequence of NO liberation from NO donors or generated by NOS. 19, 20, 34 Indeed, under normoxic conditions, NO might either activate signaling pathways that induce transcription/translation of HIF-1␣ 19 or inhibit prolyl hydroxylases activity, thereby blocking HIF-1␣ degradation. 17, 34 Alternatively, NO may cause HIF-1␣ accumulation through S-nitrosation. 34 However, we cannot rule out the possibility that NO 2 -FA-induced heme oxygenase-1 expression may also be occurring and that this could also promote angiogenesis. Notably, recently published studies 35, 36 described heme oxygenase-1 and its gaseous product, carbon monoxide, as mediators of angiogenesis by upregulating VEGF expression and increasing HIF-1␣ protein accumulation. It can therefore be hypothesized that heme oxygenase-1 and its by-products might be also involved in NO 2 -FA-dependent angiogenic events.
Although the exact molecular mechanisms underlying NO 2 -FAs-mediated HIF-1␣ upregulation are not entirely clear, our results support the fundamental role of HIF-1 in the NO 2 -FAs-induced angiogenesis. In fact, we verified that knockdown of HIF-1␣ abrogated not only NO 2 -FAs-induced EC migration but also VEGF mRNA expression, providing a mechanistic explanation of how NO 2 -FAs promote angiogenesis. Consistent with our results, previous findings have demonstrated that NO-induced cell migration was largely impaired in HIF-1␣ knockdown macrophages, suggesting that this transcription factor is critical for cell migration in response to NO. 37 In summary, this work highlights the proangiogenic properties of LNO 2 and OA-NO 2 . Moreover, we present several lines of evidence suggesting that the proangiogenic effects of both NO 2 -FAs are transmitted through NO and HIF-1␣ signaling pathways. Together, these findings disclose a novel mechanism of biological action that can be attributed to NO 2 -FAs, suggesting that these compounds might represent important mediators of angiogenesis.
